proteins
cardioprotective
expression
immunoprecipitation
cyclase
kansas city cardiomyopathy questionnaire
rvads
patient
enzyme
sinus rhythm
chromatin hyperacetylation
prospective
cardiopulmonary bypass
therapeutics
tachyarrhythmias
arterial elastance
myofiber shortening
sonographic
bioinformatic
nicorandil
extreme
cardiotoxicity
israel
frailty
quality of life
midwestern
na+
postsystolic function
breast
anaesthesia
asymptomatic
peak respiratory quotient
dilated cardiomyopathy
psoriasis
serum albumin
uptitrations
haemodynamic
heart
emergency room
acute care
ahf
acetylcholinesterase inhibition
driveline injury
hipsc
myxomas
antagonist
breast cancer
genetic
chromatin
ventricular tachycardia
blood flow velocity
infusions
chronic thromboembolic
lean mass quantification
cox regression
type ca2
shock
gut
s1pr1s
healthy
ms
south dakota
orally
pulmonary disease
intensive care unit
bb
end
lipolysis
at
arterial
zung
transfusion
epidemiology
campbell collaboration
neurohormones
contractile response
correlated
network
icd shocks
adjuvant
mass spectrometric analysis
nursing
ed
nfat
vascular diseases
vads
hypertrophic response
acs
basic
endothelial function
qol
ivabradine
ec
energy
physician
prescribing
apex
hrqol
biomedical treatment
implantation
left anterior
afterload
catabolic
emergency department
retrospective cohort study
echocardiography
left bundle branch block
0.18
pro6-gly7
euthanization
cabg
idiopathic dilated cardiomyopathy
radiological
mr
brd4
nonprescribing
ees
peak oxygen consumption
ejection fraction
nucleolin
endoplasmic reticulum
cxl-1020
btes
intravenous
heart twist
rv support
right
ecs
glomerular filtration rate
brachial index
antitachycardia pacing
adrenoceptor
osteoporosis
sts
pacemakers
morbidity
severe
magnet
beck depression inventory
rate
renal dysfunction
ventricular
veterans
gill index
cf
testosterone
healthstar
myocardial washout
kappa coefficient
ss
perfusion
bisphosphonate
{
cardiovascular society
cardiovascular system
neuronal stressors
 
circumflex artery
barriers
minnesota
rem
bisphosphonates
primary outcome
antiplatelet agents
right heart failure
body mass
na+ channel
acp
dithiothreitol
in vitro
health abc
nanomolar
posterior wall infarction
renal function
african americans
mets
net reclassification
signal transduction
angiotensin
noc
bax
msec
receptor
aric
co2
t1-mapping
lvef
t1 time
inotrope
vascular resistance
comorbidities
hemodynamically
lad
anabolic imbalance
cs
bioprosthetic
hgb
peripheral arterial
hospitalisations
heart rate
phosphorylation
tac
ivc occlusion
pde2-mediated
extubated
gata4
healthy control
crt capability
xo
ventricular action potential
sulfonylureas
obesity
dialysis
fibrosis
cell senescence
anthracyclines
heart magnetic resonance imaging
microarray
extracorporeal membrane oxygenation
or=1.65
incidence
apical
pharmaceuticals
multivariable
reduced
parasympathetic tone
uk
cytoskeleton
rationale
cv events
discharge data nonpublic file
cardiac angiogenesis
catheterization
ffm
invasively
ventricular ejection time
consultations
adrenomedullin
papillary muscles
rad
mortality
peak oxygen uptake
titin
systolic elastance
heart failure questionnaire
diastolic filling
ventricular dysfunction
significantly
injections
kappa coefficients
rem2
ventricles
citrate cycle
rv
systolic dysfunction
heartmate ii
cardiac amyloidosis
implanted cardioverter
surgical
gdmt
vasodilator
myocardial tissues
subcellular
t1
hypoalbuminemia
mva
prostate
adrenergic
midpapillary
palliative care
confirmatory factor
body
international
] ; body
hemoglobin threshold
tnf antagonist
endothelial dysfunction
chromatin structure
donors
lcx
neurological
hfpsi
% confidence
diastolic tethering
free wall
ischemic
mean
renal optimization
device
cardiac cachexia
alendronate-
attrition
cardiac washout
mapk
transcatheter
perkins
consultation
ventricular pacing
pvf
sv
life
total arterial compliance
comanagement
erythropoiesis
cohort
zsf1
xanthine oxidase inhibition
svr
protein
sympathetic nervous systems
ref
hr
interquartile range
metabolism
aortic constriction
right heart
centers
failure
myocyte
gls
randomized
cytoscape
upr
sweden
immunoblotting
rm
cardiac volume overload
cellular plasticity
allopurinol
pasp
death
lcz696
uti
cpcs
pneumonia
trichrome blue histologic
qtv
legal
blood
uptitration
exercise capacity
micrornas
pulmonary embolism
concentric remodeling
enzymes
medication
hvad
idiopathic
nitric oxide
ef
atp
icu
hh
hemodynamic assessments
clinically
brachial
condition
health care systems
ciaraldi
pharmacological
seattle heart failure model
af
biopsies
density
il6
systolic pressure
myocardial collagen
ai
or iii
diastolic pressure
vegfr2
copd
inflammatory
mitochondrial respiration
troponin
leaflet
myocarditis
patient severity index
cardiovascular reserve
regression modeling
readmission reduction
lvas
scn5a
adverse
noninvasive
t1 mapping
refractory cardiogenic shock
readmission
correlates
p
btt
β1ar
diseased
pro75-arg76
systolic   heart
odds ratio
implanted monitoring devices
end point
diastolic
immunodetection
hand grip
anticoagulation
coprimary
qrs duration
aas
pcwp
pulmonary capillary wedge pressure
infarcted
implantable cardioverter defibrillators
health organization
western blot
tapse
proteomics
ecg
gluconeogenesis
diagnosis
shift
telehealth
comorbidity
alendronate
ventricular dilatation
genotyped
ncdr pinnacle program
ea
pad
change in
guanylate cyclase
dash
bets
murine
rwt
mitral valve opening
urine volume
mechanical circulatory support
catheterisation
%
cardiac remodeling
cardiovascular function
transcription factors
etiologic
leu3-gly4
shunting
fontan failure
chelation
mri
systolic heart failure
glycolysis
sarcomeric
hospital-
plasma
myocytes
subproteomes
endothelial growth factor
minnesota living
nf
troponin t
hyperkalemia
beat
dodson
transcriptional
north america
conditions
eh
correlations
atrial
ventricular contractile reserve
invasive
stent
midregional
diuretics
rgk
insulin resistance
paf
systole
ischemic events
renal failure
heartmate
hyponatremia
prescribed
implant
complications
functional class ii
ventricle overload
maisel
renastur cohort
angii
randomization
epifluorescence microscopy
blood pressure
gene control
ventricular assist device
fully
pathogenesis
hazard analyses
genotype
pf
prognosis
hungary
antihyperglycemic agents
secondary endpoints
body fat distribution
bcl-2
hyperinsulinemia
molecular
cardiopulmonary exercise test
polymerase ii
followed
natriuretic
vad
functional status
health
cyclic guanosine monophosphate
ctnt
p70s6k
murphy
medicaid services
intermacs
angiotensin system
phenylephrine
ventricular assist device support
naviaux
hospitals
ethically
coronary arteries
bisphophonates
significant
nri
transient
pulmonary hypertension
icc
stem cell
inotropic effect
progenitor function
tricuspid
deactivation
mir-25
preserved ejection fraction
pathobiology
genomic
ventricle
periodic breathing
heart failure with
new zealand
beck
sympathovagal balance
pathophysiologic
hf
tgf
angiography
chf
hf units
tm
dcm
mammalian enabled
nephropathy
cochrane
hemostasis
physical
multivariable adjustment
ventricular action potentials
longitudinal study
central blood pressure
pioglitazone
prognostically
chordal ruptures
cpg
isoforms
ventricular mechanics
hno donor
pleasanton
nontrastuzumab
dtt]-insensitive
biomarker
randomize
ambulatory
sympathetic
fibrillation
vo
strain
implants
surgically
precapillary ph
ventricular diastolic
reverse
kidney disease
ventricular pump function
medically
heart failure index
septal wall
ecgs
frail
cvd
systolic function
fluorescence resonance energy transfer
surgical palliation
stable body
arni
transplantation
dna fragmentation
contemporaneous control
propensity score
sd
pd
pulmonary artery
sarcomere shortening
defibrillator
icd
pulsatile devices
mechanical dyssynchrony
lean
diastolic stiffness
osteomedullary biopsy
vegf expression
embase
aldosterone
type 2 diabetes
randomised
clinicians
na+ channels
cinahl
health care
;
autonomic imbalance
defibrillators
kidney failure
exercise
europe
cr
health insurance board
lvads
japan
vascular
peripheral edema
degs
structured
healthcare common procedure coding system codes
type 2
lbbb
neurohormonally
breathing control
nuclear factor
physicians
futility
cv
nephrectomy
cox models
endothelial cell
outpatients
anticoagulants
hemoglobin
adverse event
mena
cardiomyocytes
t2d
eplerenone
neuro
calreticulin
lesion
autonomic balance
cellular dysfunction
multivariable regression
vasopressin receptor antagonist
downstream signalling
lvad
vena cava
icds
coronary artery occlusion
vasodilatory
nitroxyl
ie
myocyte depolarization
rad variant
kccq
left
or
cfa
myocardial extracellular matrix
neoangiogenesis
multiple myeloma
muscular
paucity
pulse
unfolded protein response
psychosocial
health system
st2
myocardial function
canadian
vco2
framingham
collagen
mitochondrial energy production
systolic
cardioprotective signaling
medicare
myocardium
x
nurse
eds
percutaneous
myxoma
collins
prevalence
myocardial ischemia
transcriptional pause release
chemotherapy
ckd
nonsignificant
aortic valve
risk
holosystolic murmur
atrial pressure
pol ii
urine
primary
leaflet resection
ischemic cardiomyopathy
pb
health initiative
angiotensin ii
ventricular assist system
genes
vascular endothelial growth factor
titin hypophosphorylation
hospitalisation
cardiac defibrillator
epithelial
perk
sa
regression models
bet
etiology
clinician
lv dilatation
clcnka
outcomes
inpatient
hypokalemia
terminal
pharmaceutically
cxl-1051
metoprolol succinate
neurohormonal
aldosteron
psss
sepsis
baseline
no
aortic valve insufficiency
specificity
gastrointestinal bleeding
renal denervation
cha₂ds₂vasc score
muscle
insulin
aortic valve replacement
cardiac magnetic resonance imaging
cochrane library
hemocompatibility
nbdmards
transplant
dilated
carbohydrates
point
homozygous
ring annuloplasty
remodeling
followed up
hdl
infusion
longitudinal
lv
protein kinase
cardiac failure
dpp-4
diabetes mellitus
ventricular pressure overload
resuscitation
ventricular dyssynchrony
interventricular delay
sympathetic outflow
mitochondrial dysfunction
correlation
diastole
doxorubicin
isoproterenol
emd
seattle
mdc
epicatechin
biomarkers
heart  
thromboembolic events
hart
100
aucs
hogan
cardiac hypertrophy
cardiac magnetic resonance
rna
grade
transcription factor
massive embolism
intubation
ch
peptide
neurotransmission
ventricular wall stress
tonometry
von willebrand factor
kidney disease epidemiology collaboration
perceived
cardiac filling
phosphodiesterase-2
spironolactone
tunel
arg83gly
diuretic
adipose tissue
patients with
clinic
glucocorticoids
lokomat
regression analyses
volume
baseline ef
end points
renin
disease
canada
receptors
hm
left bundle
6mwt
transfusions
physical performance battery
endothelial
new jersey
peripheral artery disease
atherosclerosis
biomedical
raas
pyridostigmine
ventricular filling
rnas
mrna splicing
drug
atrial structure
pubmed
[
vasopressin
hypertrophy
salt loading
olmsted county
signaling pathways
hearts
explants
acetyltransferases
aortic insufficiency
renal disease
standard error
relative risk
cardiac support
pathological stress
overload
lv function
electromechanical delay
calcineurin
np
rehabilitation
monocytes
cox
gene
left atrial area
reduced ef
primary end point
acf
glucocorticoid
stroke volume
east
pathophysiological
new york
dxa
anand
nps
psycinfo
sinus
surgeons
qrs
david
hek
alberta
cancers
testosterone supplementation
ventricular assist devices
vascular stiffness
monomeric
prospectively
long axis function
hr reduction
crf
heart disease
jq1
texas
health status
nyha classification
review
myocardial fibrosis
life expectancy
valve plasty
cardiac event
cardiovascular event
clinics
parasympathetic activity
nonischemic cardiomyopathies
plasma membrane
implantable defibrillators
hhf
heart rate reduction
myocytes with volume overload
urinary tract infection
cystatin c
clinical excellence registry
postoperatively
joint
in vivo
tidal respiration
chop
medicine
rotterdam
resynchronization
shunts
heartware
qrs complex
hospital compare
nhs
bromodomain
transverse aortic constriction
crossover
neurohormone
psychometric
third heart sound
with
rvad
standard error of measurement
trastuzumab
haplotype
bhlh
electrocardiographers
leaflet motion
functional class
ventricular ejection fractions
ste
for stroke
sensitivity
diastolic murmurs
or shock
quality
aac
systolic blood pressure
stroke
multicenter automatic
hypertension
metoprolol
irs1
habc battery
transplants
anaerobic threshold
coagulability
clinical practice
defibrillator device
ventricular support
epidemic
filling pressures
latin america
circulatory support)-derived
coronary artery disease
functional enrichment
functional enrichment analysis
kidney
nonterminal
symptom
medications
neprilysin inhibitor
)
receptor blockers
terminal stage
prodrug
arrhythmia
peripheral muscle pump
therapies
bivp
multisystem disease
implanted
québec
cri
sst2
vvd
phenotypes
bnp
new york heart association class i
cardiovascular
qrs morphology
immunoreactive
hospitalizations
raloxifene
mitochondrial function
crt
lv mass
mlhf questionnaire
doppler
diagnostic
angina
prognostic
osprey
fontan
intubations
preoperative
prolapse
symptomatic
lesions
proteolysis
deficit
aldosterone pathway
ventricular function
nosignificant
right coronary artery
ambulatory heart failure
inflammation
hospital
egfr)-group
shunt
less
cell
cardiac stress
diastolic function
dyspnea
vegf
covariates
parasympathetic control
patients
cpgs
echocardiograms
diagnosed
reverse remodeling
bisoprolol
minimal detectable change
histological
injected
autonomic
ph
ivc
tuscany
misdiagnosis
outpatient
cardiac index
cohort study
correlation coefficient
bleeding
body mass index
biventricular pacing
cardiac arrest
interquartile
cross talk
tug
phenotype
rotterdam study
clinical
rate control
cardiac biology
cardiac
stable heart failure
admissions
tonometric
data
italy
cox modeling
calif
metabolic
avd
qrs prolongation
,
hfref
mitochondrial
extracorporeal support
breathing
systolic heart
myocardial
nesiritide
myoctyes
egfr
exercise testing
doctors
implantable cardioverter
cpet
esrd
ecmo
fluid overload
saxagliptin
intubated
epigenetic
s1pr1
ra
tumor necrosis factor
fes
transgenic
toronto
histologically
aortocaval fistula
cardiopulmonary
raft
dt
autonomic nervous system activity
renal underperfusion
skinfold
degenerative
mitral valve
diastolic failure
pef
methotrexate
rs
bat
cachexia
nbdmard
medicines
dna
pathological
postoperative
peak quadriceps force
ingenuity pathway
gse9128
methodology
akt
etidronate-
regression
systolic hf
ventricular cardiomyocytes
anemia
video edge detection
pka
was
skeletal muscle mass
symptoms
university
serum
new york heart association class
sympathetic activity
antagonists
deaths
confidence interval
taub
dementia
randomized aldactone evaluation
camp
cytoskeletal actin dynamics
proteomic
drs)-stratified analyses
cardiology
centre for reviews
tug test
ring
 
vt
readmissions
implantable cardioverter defibrillator
confidence intervals
eov
shuttle walk test
ppr
hemodynamic
peripheral muscles
auc
healthcare
vegf signaling pathway
ami
dacron patch closure
schfi v.6.2
histone
biventricular dysfunction
pharmacologic
coronary artery bypass grafting
prospective study
pronto
medical treatment
dhand
cc
hfpef
yorkshire
mitral valve plasty
ss31
functional capacity
cardiac function
heart study
fm
neurohormonal systems
systolic volume
rvpo
anthracycline
physiologic processes
myosin
air
pathophysiology
international classification of diseases
differential
aortic pressure curve
habc
inotropes
circulation
hand2
stable
aetiologies
cardiovascular events
united states
pro2-leu3
design
telehealth system
fat mass
hazard ratio
regression analysis
atherosclerosis risk
telemonitoring
relative
cardiologists
tnf antagonists
mitral regurgitation
repolarization
australia
risk stratification
ies
hscrp
hemodynamic disorder
bpm
sickle cell disease
hypoxia
antibodies
area under
randomized control
cgmp
tissue
gene expressions
signaling pathway
heart failure
systemic
ventricular diastolic function
northern california
world
nonterminal epitopes
chronic
remodelling
ss20
candesartan
polymorphisms
hno
rs10927887
stenotic physiology
confidence
transmitral
sitagliptin
heart block
health buddy program
rv dysfunction
exploratory factor
cox proportional hazards analyses
cox regression models
be
liver
alphalisa
primary endpoint
pna
explant
endothelin
rose
circulatory assist device
therapeutic
coronary angiography
lipoprotein
cis
health planning and
dysfunction
diseases
af ablation
surgery
mi
cardiac growth
polytetrafluoroethylene tube
readmission rate
placebo
resistin
extracorporeal life support
cad
gene expression
centres
ischemic cerebrovascular
ventricular filling pressure
rcts
bolus
skeletal muscle
resting tension
fpassive)-sarcomere
hazard ratios
quality of
absorptiometry
peptidase-4
vo2
cyclic adenosine monophosphate
nyha
diastolic dysfunction
tolvaptan
molecular scaffolds
ras
cellular
rales
university of michigan
carvedilol
cardiomyiopathy
admission
nris
gene expression profile
mri scanner
skm
trastuzumb
reoperation
cardiorespiratory
sternal
nurses
ventricular contractile function
lv assist device implantation
camp hydrolysis
revascularization
adverse event profile
pacemaker
rv function
post hoc analysis
enzyme inhibitor
cardioprotection
compliance
dopamine
concentric
uninephrectomy
haemodynamic stress
adjusted odds
postmenopausal
adverse events
preserved
pde2
open chest model
tricuspid valve
valsartan
charm
progenitors
probnp
gastrointestinal
septal defects
functional
myocardial dd
apoptosis
fat free mass
extracorporeal membrane
new york heart association class ii
sarcomere
correlate
co
adipokines
petco2
tumors
heart failure.(1
.59
astronaut
decompensated
downregulation
rehospitalization
retrospective
centrifugal flow pump
explanted
joanna briggs institute
dakota
protein kinase r
rheumatoid arthritis
edwards lifesciences
healthcare programmes
glucose
sodium
new york heart association
cardiovascular disease registry practice
colon
pulsatile afterload
therapy
vascular disease
acute
obese
sternotomy
drugs
discharge
biologic
ventricularly
ic
in
mpsms
hospitalized
odds ratios
iron homeostasis
β1ars
syndromes
stenosis
sympathetic tone
peptides
protein 4
echocardiographic
syndrome
electrolytes
of heart
fontan circulation
oht
lusitropic
neurohormonal activation
leaflet opening
hospitalization
mrna splice
mass spectrometry
diabetes
pathology
mitral annulus velocity
myocardial infarction
urban academic
mitral
serum potassium
irs2
ecct
progenitor cells
acr
cardiac output
university health network
infarction
extracorporeal membrane oxygenation membrane support
medline
cox proportional hazards models
reduced ejection fraction
.
no synthase
neurohormonal stimulation
hazard models
lvet
vad support
filling time
polymorphism
antagonism
inflammatory state
glycosylated
hyperlipidaemia
denmark
and salt
thrombotic obstruction
tta
receptor antagonists
medicaid
atrioventricular delay
kyoto
ceballos
catheter ablation
tachycardia
anoop shah
multiorgan failure
transcription
titrated
caspase-3
significance
ventricular ejection fraction
ontario case
lean mass
discharged
cells
organ failure
tertiary
hr dynamics
saf
thoratec corp
parasympathetic function
continuous flow
compared
immunoassays
bmi
neprilysin
medical
ci
lung congestion
randomized aldactone
deficit index
outcome
nitrite
mild hf
anastomosis
biventricular support
inotropic
hypertensive hfpef
renal
cms
cgmp synthesis
cpr
medical support
implantable
adiponectin
